James McCracken, M.D.
Professor, Director, UCLA Child and Adult Neurodevelopmental Clinic
Director, Division of Child and Adolescent Psychiatry
Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA
Joseph Campbell Chair in Child Psychiatry
David Geffen School of Medicine at UCLA
Dr. James McCracken is the Joseph Campbell Chair in Child Psychiatry and Director of the Division of Child and Adolescent Psychiatry at the David Geffen School of Medicine at UCLA. Dr. McCracken is recognized as a leading authority on the testing of new treatments for children, adolescents, and adults with autism spectrum disorder (ASD) and related conditions, such as attention-deficit/hyperactivity disorder, anxiety, and cognitive disorders. He is the Founder and Director of the UCLA Child and Adult Neurodevelopmental Clinic (CAN), the primary clinical service for individuals of all ages with ASD affiliated with CART. Dr. McCracken is the principal investigator of the National Institute of Mental Health “New Experimental Medicine Studies: Fast-Fail Trials for Autism Spectrum Disorders,” which aims to develop methods and rapidly test promising novel medical treatments for core deficits of autism. Dr. McCracken’s other areas of treatment research include examining the combination of medical treatments to enhance the effects of behavioral and cognitive interventions, and the testing of other new pharmacologic and cognitive treatments for a variety of neuropsychiatric disorders in children. Dr. McCracken has received numerous awards for his research, published more than 300 papers and chapters in the area of child psychiatry, and serves on the editorial board of the journal Molecular Autism. Dr. McCracken is an active clinician and has been included in America’s Top Doctors, Best Doctors, and SuperDoctors listings for more than a decade.